Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor
Open accessAbstract
Arginine vasopressin (AVP) stimulates ACTH release in man and acts synergistically with synthetic ovine corticotropin-releasing factor (oCRF) in vitro. This study was designed to examine in man the combined effects of synthetic AVP (10 U intramuscularly) and oCRF (1 micrograms/kg intravenously) on ACTH release. Five normal male volunteers participated in five separate experiments: (a) AVP alone; (b) oCRF alone; (c) AVP followed by oCRF 15 min later; (d) simultaneous AVP and oCRF; and (e) insulin-induced hypoglycemia. Plasma immunoreactive ACTH (IR-ACTH) and IR-cortisol were measured for 4 h after injection of each hormone; basal levels for all subjects were less than or equal to 9 +/- 1.2 pg/ml and 4.9 +/- 0.4 micrograms/dl (mean +/- SE), respectively. AVP and oCRF, when given individually, caused rapid rises in IR-ACTH to similar peak levels of 25 +/- 6.6 and 33 +/- 4.6 pg/ml, respectively. AVP given 15 min before oCRF caused a 2.6-fold potentiation of the oCRF response, with a peak IR-ACTH of 85 +/- 4.6 pg/ml. AVP given at the same time as oCRF produced a fourfold potentiation of the peak IR-ACTH response to 132 +/- 11 pg/ml. These ACTH responses were far greater than those previously observed after 30-fold greater doses of oCRF alone. By way of comparison, insulin-induced hypoglycemia caused a peak IR-ACTH of 169 +/- 20 pg/ml. IR-ACTH returned to base line at 60-90 min after AVP alone, whereas the prolonged effect of oCRF was apparent whether it was given alone or in combination with AVP. The mean peak IR-cortisol responses to AVP, oCRF, and AVP given 15 min before oCRF were similar (16.5 +/- 0.9, 16.4 +/- 2.3, and 18.5 +/- 0.8 micrograms/dl, respectively), but the peak IR-cortisol responses to AVP and oCRF given simultaneously and to insulin-induced hypoglycemia were 1.5 and 1.7 times greater, respectively. IR-cortisol returned to base line within 2-3 h after AVP alone, but remained elevated for at least 4 h after oCRF alone or in combination with AVP. These results indicate that AVP acts synergistically with oCRF to release ACTH in man and suggest that AVP may play a physiologic role in modulating the ACTH response mediated by corticotropin-releasing factor.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
On receipt of the neuronal signal from the amygdala and locus coeruleus, numerous neuropeptides are released from the hypothalamus, including arginine vasopressin (AVP) and stress-induced corticotropin-releasing factor/hormone (CRF/H).
“On receipt of the neuronal signal from the amygdala and locus coeruleus, numerous neuropeptides are released from the hypothalamus, including arginine vasopressin (AVP) and stress-induced corticotropin-releasing factor/hormone (CRF/H) (90).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [90]
The Introduction (page unavailable) identifies AVP and CRF with the hypothalamus and discusses their roles in ACTH secretion. It does not say that signals from the amygdala and locus coeruleus cause the hypothalamus to release these or other neuropeptides; the study instead examines ACTH responses to administered AVP and CRF. (LLM, conf=0.86)
Experimental — accuracy not yet measuredBoth in human and in rat, the CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [45]
The Introduction (page unavailable) calls CRF a physiologically important mediator of ACTH secretion, describes ovine CRF as a potent stimulus in humans, and cites evidence that vasopressin plays only a minor role in rats. It does not establish that the CRH pathway is dominant in both species: the Discussion (page unavailable) reports similar ACTH and cortisol responses to comparable doses of ovine CRF and vasopressin in humans and cautions that ovine and human CRF may not have identical activities. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Principles and Procedures of Statistics
Robinson, H. F. (1961) · Agronomy Journal · doi:10.2134/agronj1961.00021962005300050002x · Cited by 17,727 · see citing works
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · see citing works
Self-citationVale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904 · see citing works
Self-citationCorticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · see citing works
RIVIER, C. L., Brownstein, M. J., Spiess, J., Rivier, J., & Vale, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555 · see citing works
Self-citationPrimary structure of corticotropin-releasing factor from ovine hypothalamus
Spiess, J., Rivier, J., Rivier, C., & Vale, W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6517 · Cited by 424 · see citing works
Self-citationIsolation and sequence analysis of the human corticotropin‐releasing factor precursor gene.
Shibahara, S., Morimoto, Y., Furutani, Y., Notake, M., Takahashi, H. K., Shimizu, S., Horikawa, S., & Numa, S. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01499.x · Cited by 419 · see citing works
Corticotropin-Releasing Factor*
YASUDA, N., Greer, M. A., & Aizawa, T. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-123 · Cited by 322 · see citing works
Rapid radioimmunoassay for corticotropin in unextracted human plasma.
Nicholson, W. E., Davis, D. R., Sherrell, B. J., & Orth, D. N. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.2.259 · Cited by 280 · see citing works
Self-citationOrth, D. N., Jackson, R. V., DeCherney, G. S., DEBOLD, C. R., ALEXANDER, A. N., Island, D. P., Rivier, J., RIVIER, C. L., Spiess, J., & Vale, W. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110804 · Cited by 246 · see citing works
Self-citationPotentiation by Vasopressin of Corticotropin Release Induced by Corticotropin-Releasing Factor1
Yates, F. E., Russell, S. M., Dallman, M. F., Hedge, G. A., McCann, S. M., & DHARIWAL, A. P. S. (1971) · Endocrinology · doi:10.1210/endo-88-1-3 · Cited by 245 · see citing works
Corticotrophin releasing factor may be modulated vasopressin
Gillies, G. E., & Lowry, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174 · see citing works
Site of Action of Vasopressin in Causing Corticotropin Release1
Hedge, G. A., Yates, M. B., Marcus, R., & Yates, F. E. (1966) · Endocrinology · doi:10.1210/endo-79-2-328 · Cited by 132 · see citing works
Giguère, V., & Labrie, F. (1982) · Endocrinology · doi:10.1210/endo-111-5-1752 · Cited by 128 · see citing works
Substances modulating the secretion of ACTH by cultured anterior pituitary cells.
Vale, W., & River, C. (1977) · PubMed · Cited by 101 · see citing works
Self-citationTHE ACTH-RELEASING ACTIVITY OF EXTRACTS OF THE POSTERIOR LOBE OF THE PITUITARY IN VIVO1
McCann, S. M. (1957) · Endocrinology · doi:10.1210/endo-60-5-664 · Cited by 92 · see citing works
Roth, K. A., Weber, E., & Barchas, J. D. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90228-4 · Cited by 73 · see citing works
DEBOLD, C. R., DECHERNEY, G. S., JACKSON, R. V., SHELDON, W. R., ALEXANDER, A. N., ISLAND, D. P., RIVIER, J., VALE, W., & ORTH, D. N. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-294 · Cited by 71 · see citing works
Self-citationGillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60 · see citing works
Isolated Pituitary Cells: CRF-Like Activity of Neurohypophysial and Related Polypeptides
Portanova, R. P., & Sayers, G. (1973) · Experimental Biology and Medicine · doi:10.3181/00379727-143-37386 · Cited by 55 · see citing works
Nicholson, W. E., DeCherney, G. S., Jackson, R. V., DEBOLD, C. R., Uderman, H. D., ALEXANDER, A. N., Rivier, J., Vale, W., & Orth, D. N. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1263 · Cited by 50 · see citing works
Self-citationAdrenocorticotropin,β-Endorphin, and Corticosterone Secretion in Brattleboro Rats*
Conte‐Devolx, B., Giraud, P., Oliver, C., Castanas, E., Boudouresque, F., Gillioz, P., & MILLET, Y. (1982) · Endocrinology · doi:10.1210/endo-110-6-2097 · Cited by 46 · see citing works
Staub, J. J., Jenkins, J. S., Ratcliffe, J. G., & Landon, J. (1973) · BMJ · doi:10.1136/bmj.1.5848.267 · Cited by 42 · see citing works
Studies on the Site of Action of Vasopressin in Inducing Adrenocorticotropin Secretion*
YASUDA, N., Greer, M. A., Greer, S. E., & Panton, P. (1978) · Endocrinology · doi:10.1210/endo-103-3-906 · Cited by 42 · see citing works
A Semi-Automated in vitro Assay for CRF: Activities of Peptides Related to Oxytocin and Vasopressin
Pearlmutter, A. F., Rapino, E., & Saffran, M. (2008) · Neuroendocrinology · doi:10.1159/000122299 · Cited by 37 · see citing works
CORTICOTROPHIN RELEASING ACTIVITY IN EXTRACTS OF THE STALK MEDIAN EMINENCE OF BRATTLEBORO RATS
Gillies, G. E., & Lowry, P. J. (1980) · Journal of Endocrinology · doi:10.1677/joe.0.0840065 · Cited by 37 · see citing works
Spiess, J., Rivier, J., & Vale, W. (1983) · Biochemistry · doi:10.1021/bi00287a027 · Cited by 34 · see citing works
Self-citationBuckingham, J. C. (1981) · The Journal of Physiology · doi:10.1113/jphysiol.1981.sp013612 · Cited by 27 · see citing works
Is corticotropin releasing factor modulated vasopressin?
Pearlmutter, A. F., Dokas, L. A., Kong, A., Miller, R. E., & Saffran, M. (1980) · Nature · doi:10.1038/283697b0 · Cited by 15 · see citing works
McDonald, R. K., & Weise, V. K. (1956) · Experimental Biology and Medicine · doi:10.3181/00379727-92-22518 · Cited by 12 · see citing works
RIVIER, C. L., Vale, W. W., & Guillemin, R. (1973) · Experimental Biology and Medicine · doi:10.3181/00379727-142-37129 · Cited by 10 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [4]4. Vale, W. W., C. Rivier, J. Spiess, M. R. Brown, and J. Rivier. 1983. Corticotropin-releasing factor. In Brain Peptides. D. Krieger, M. Brownstein, and J. Martin, editors. John Wiley & Sons, Inc., New York. 961-974.
Cited by
Sorted by citations
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270 · see citing works
Self-citationThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833 · see citing works
Hostinar, C. E., Sullivan, R. M., & Gunnar, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0032671 · Cited by 739 · see citing works
Orth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 562 · see citing works
Self-citationRole of stress in the pathogenesis of the metabolic syndrome
Rosmond, R. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.007 · Cited by 516 · see citing works
Mediation by Corticotropin Releasing Factor (CRF) of Adenohypophysial Hormone Secretion
RIVIER, C. L., & Plotsky, P. M. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.002355 · Cited by 443 · see citing works
Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?
CARTER, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.025 · Cited by 432 · see citing works
Corticotropin-releasing hormone receptor subtypes and emotion
Steckler, T., & Holsboer, F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00170-5 · Cited by 323 · see citing works
The Neuroendocrinology of Chronic Fatigue Syndrome
Cleare, A. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0014 · Cited by 315 · see citing works
Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W., & Lee, K. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00193.2002 · Cited by 293 · see citing works
Self-citationEpigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288 · see citing works
“On receipt of the neuronal signal from the amygdala and locus coeruleus, numerous neuropeptides are released from the hypothalamus, including arginine vasopressin (AVP) and stress-induced corticotropin-releasing factor/hormone (CRF/H) (90).”
BackgroundScott, L. V., & Dinan, T. G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00027-7 · Cited by 281 · see citing works
Stress sensitivity and the development of affective disorders
Bale, T. L. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.033 · Cited by 243 · see citing works
Schlotz, W., Kumsta, R., Layes, I., Entringer, S., Jones, A., & Wüst, S. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181810658 · Cited by 237 · see citing works
BERTAGNA, X. Y., Guignat, L., Groussin, L., & Bertherat, J. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 221 · see citing works
Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review
Gibbs, D. M. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90048-x · Cited by 192 · see citing works
Multiple sclerosis is associated with alterations in hypothalamic- pituitary-adrenal axis function
Michelson, D., Stone, L., Galliven, E., Magiakou, M. A., Chrousos, G. P., Sternberg, E. M., & Gold, P. W. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077372 · Cited by 175 · see citing works
Corticotropin-Releasing Hormone
Taylor, A. L., & Fishman, L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190405 · Cited by 175 · see citing works
Biller, B. M. K., Federoff, H. J., Koenig, J. I., & Klibanski, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-311 · Cited by 173 · see citing works
Erkut, Z. A., Pool, C. W., & Swaab, D. F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4881 · Cited by 155 · see citing works
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 141 · see citing works
Sex Differences in Response to Stress and Expression of Depressive-Like Behaviours in the Rat
Dalla, C., Pitychoutis, P. M., Kokras, N., & Papadopoulou‐Daifoti, Z. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_94 · Cited by 134 · see citing works
Newell-Price, J. D. C., Perry, L., Medbak, S., Monson, J. P., Savage, M. O., Besser, M., & Grossman, A. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3674 · Cited by 126 · see citing works
Sensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 122 · see citing works
Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase
Galliven, E. A., Singh, A., Michelson, D., Bina, S., Gold, P. W., & Deuster, P. A. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.1822 · Cited by 116 · see citing works
Vasopressin receptor expression and mutation analysis in corticotropin- secreting tumors
Dahia, P. L. M., Ahmed-Shuaib, A., Jacobs, R. A., Chew, S. L., Honegger, J. B., Fahlbusch, R., BESSER, G. M., & Grossman, A. B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626831 · Cited by 116 · see citing works
In the trout, CRH and AVT synergize to stimulate ACTH release
Baker, B. I., Bird, D. J., & Buckingham, J. C. (1996) · Regulatory Peptides · doi:10.1016/s0167-0115(96)00130-9 · Cited by 110 · see citing works
Dinan, T. G., & Scott, L. V. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00443.x · Cited by 110 · see citing works
Scott, L. V., Medbak, S., & Dinan, T. G. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10030.x · Cited by 106 · see citing works
Bornstein, S., WEBSTER, E. L., Torpy, D. J., Richman, S. J., Mitsiades, N., Igel, M., Lewis, D. B., Rice, K. C., Joost, H., Tsokos, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.4.5938 · Cited by 104 · see citing works
Schulte, H. M., Chrousos, G. P., Gold, P. W., Booth, J. D., Oldfield, E. H., Cutler, G. B., & Loriaux, D. L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111890 · Cited by 103 · see citing works
Ectopic pro-opiomelanocortin syndrome
Beuschlein, F., & Hammer, G. D. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00025-1 · Cited by 101 · see citing works
Goncharova, N. D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00026 · Cited by 99 · see citing works
Corticotropin-releasing hormone physiology
Majzoub, J. A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02247 · Cited by 92 · see citing works
SHELDON, W. R., DEBOLD, C. R., Evans, W. S., DeCherney, G. S., Jackson, R. V., Island, D. P., Thorner, M. O., & Orth, D. N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-623 · Cited by 87 · see citing works
Self-citationSalata, R. A., Jarrett, D. B., Verbalis, J. G., & Robinson, A. G. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113382 · Cited by 84 · see citing works
DeCherney, G. S., DEBOLD, C. R., Jackson, R. V., SHELDON, W. R., Island, D. P., & Orth, D. N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-2-273 · Cited by 83 · see citing works
Self-citationElias, L. L. K., Antunes‐Rodrigues, J., Elias, P. C. L., & Moreira, A. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3884 · Cited by 82 · see citing works
WATANABE, T., & ORTH, D. N. (1987) · Endocrinology · doi:10.1210/endo-121-3-1133 · Cited by 80 · see citing works
Self-citationIncreased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis
Erkut, Z. A., Hofman, M. A., Ravid, R., & Swaab, D. F. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00098-m · Cited by 79 · see citing works
Vasopressin as a target for antidepressant development: an assessment of the available evidence
Scott, L. V., & Dinan, T. G. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00026-5 · Cited by 78 · see citing works
Effect of Altered Thyroid Hormone Levels on Hypothalamic-Pituitary-Adrenal Function*
Kamilaris, T. C., DEBOLD, C. R., PAVLOU, S. N., Island, D. P., HOURSANIDIS, A., & Orth, D. N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-994 · Cited by 78 · see citing works
Self-citationMichelson, D., Galliven, E., Hill, L., Demitrack, M. A., Chrousos, G. P., & Gold, P. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4172 · Cited by 75 · see citing works
Hormonal Responses to Insulin-Induced Hypoglycemia in Man*
Watabe, T., TANAKA, K., Kumagae, M., Itoh, S., Takeda, F., Morio, K., HASEGAWA, M., HORIUCHI, T., Miyabe, S., & Shimizu, N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1187 · Cited by 75 · see citing works
Vassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 74 · see citing works
Rittmaster, R. S., Cutler, G. B., Gold, P. W., Brandon, D. D., Tomai, T. P., Loriaux, D. L., & Chrousos, G. P. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-2-371 · Cited by 70 · see citing works
Avgerinos, P. C., Schürmeyer, T. H., Gold, P. W., Tomai, T. P., Loriaux, D. L., Sherins, R. J., Cutler, G. B., & Chrousos, G. P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-816 · Cited by 69 · see citing works
Torpy, D. J., & Chrousos, G. P. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80014-8 · Cited by 67 · see citing works
Milsom, S. R., Conaglen, J. V., Donald, R. A., Espiner, E. A., Nicholls, M. G., & Livesey, J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb02998.x · Cited by 66 · see citing works
Kathol, R. G., Jaeckle, R. S., López, J. F., & Meller, W. H. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.4.468 · Cited by 66 · see citing works
Corticotropin-releasing factor (CRF) — a review
Emeric-Sauval, E. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90014-4 · Cited by 57 · see citing works
Ogilvie, K. M., Lee, S., & RIVIER, C. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01082-7 · Cited by 57 · see citing works
Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants
Rizvi, Z. B., Aniol, H. S., Myers, T. F., Zeller, W. P., Fisher, S. G., & Anderson, C. L. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81971-7 · Cited by 56 · see citing works
Kuhn, J., Proeschel, M. F., Seurin, D., BERTAGNA, X. Y., LUTON, J. P., & Girard, F. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90443-9 · Cited by 54 · see citing works
Deuster, P. A., Petrides, J. S., Singh, A. P., Lucci, E. B., Chrousos, G. P., & Gold, P. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5110 · Cited by 53 · see citing works
Makara, G. B., Mergl, Z., & Zelena, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.018 · Cited by 51 · see citing works
Dickstein, G., DEBOLD, C. R., Gaitan, D., DeCherney, G. S., Jackson, R. V., Sheldon, W. R., Nicholson, W. E., & Orth, D. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768855 · Cited by 49 · see citing works
Self-citationChronobiology of the Hypothalamic-Pituitary-Adrenal and Renin-Angiotensin-Aldosterone Systems
Angeli, A., Gatti, G., & Masera, R. G. (1992) · Springer eBooks · doi:10.1007/978-3-642-78734-8_22 · Cited by 48 · see citing works
Adrenocorticotropic hormone and cortisol in calves after corticotropin-releasing hormone.
Veissier, I., van Reenen, C. G., Andanson, S., & Leushuis, I. E. (1999) · Journal of Animal Science · doi:10.2527/1999.7782047x · Cited by 47 · see citing works
Gagliardi, L., Hotu, C., Casey, G. J., Braund, W. J., Ling, K., Dodd, T. J., Manavis, J., Devitt, P. G., Cutfield, R. G., Rudzki, Z., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03471.x · Cited by 45 · see citing works
A Complex Mechanism of Facilitation in Pituitary Acth Cells: Recent Single-Cell Studies
Leong, D. A. (1988) · Journal of Experimental Biology · doi:10.1242/jeb.139.1.151 · Cited by 43 · see citing works
Handbook of depression and anxiety
Kasper, S. F., den Boer, J. A., & Sitsen, J. M. A. (2003) · M. Dekker eBooks · Cited by 43 · see citing works
Torpy, D. J., Grice, J. E., Hockings, G. I., Walters, M. M., Crosbie, G. V., & Jackson, R. V. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027217 · Cited by 42 · see citing works
Self-citationAspirin Inhibits Vasopressin-Induced Hypothalamic-Pituitary-Adrenal Activity in Normal Humans
Nye, E. J., Hockings, G. I., Grice, J. E., Torpy, D. J., Walters, M. M., Crosbie, G. V., Wagenaar, M., Cooper, M., & Jackson, R. V. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3820 · Cited by 41 · see citing works
Self-citationDose Response of Adrenocorticotropin and Cortisol to the CCK-B Agonist Pentagastrin
Abelson, J. L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00124-9 · Cited by 41 · see citing works
WATABE, T., TANAKA, K., KUMAGAE, M., ITOH, S., KOGURE, M., HASEGAWA, M., HORIUCHI, T., MORIO, K., TAKEDA, F., UBUKATA, E., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1132 · Cited by 39 · see citing works
The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing’s Disease
Fukuoka, H., Shichi, H., Yamamoto, M., & Takahashi, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239132 · Cited by 39 · see citing works
Abnormalities in response to vasopressin infusion in chronic fatigue syndrome
Altemus, M. M. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00044-5 · Cited by 39 · see citing works
BERTAGNA, X. Y., Coste, J., Raux-Demay, M. C., Letrait, M., & Strauch, G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.390 · Cited by 38 · see citing works
Livesey, J., Donald, R. A., IRVINE, C. H. G., Redekopp, C., & Alexander, S. L. (1988) · Endocrinology · doi:10.1210/endo-123-2-713 · Cited by 37 · see citing works
Laboratory differentiation of Cushing's syndrome
Reimondo, G., Pia, A. R., Bovio, S., Allasino, B., Daffara, F., Paccotti, P., Borretta, G., Angeli, A., & Terzolo, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.036 · Cited by 36 · see citing works
Burnett, F., Scott, L. V., Weaver, M. G., Medbak, S., & Dinan, T. G. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00127-x · Cited by 35 · see citing works
Gaillard, R. C., Riondel, A. M., LING, N. C., & Muller, A. F. (1988) · Life Sciences · doi:10.1016/s0024-3205(88)80012-2 · Cited by 35 · see citing works
Giraldi, F. P., & Cavagnini, F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci443 · Cited by 34 · see citing works
The HPA axis response to insulin hypoglycemia in depression
López, J. F., Kathol, R. G., Jaeckle, R. S., & Meiler, W. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90226-5 · Cited by 33 · see citing works
Effect of Naloxone on the Hormone Response to crf in Normal man
Conaglen, J. V., Donald, R. A., Espiner, E. A., Livesey, J., & Nicholls, M. G. (1985) · Endocrine Research · doi:10.3109/07435808509035423 · Cited by 32 · see citing works
Favrod-Coune, C. A., Raux-Demay, M. C., Proeschel, M. F., BERTAGNA, X. Y., Girard, F., & LUTON, J. P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00522.x · Cited by 32 · see citing works
Hensen, J., Hader, O., Bähr, V., & Oelkers, W. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-668 · Cited by 32 · see citing works
Watanabe, T., Oki, Y., & Orth, D. N. (1989) · Endocrinology · doi:10.1210/endo-125-4-1921 · Cited by 31 · see citing works
Self-citationKang, S. W., & Kuenzel, W. J. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.04.018 · Cited by 30 · see citing works
Scott, L. V., Medbak, S., & Dinan, T. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00232-7 · Cited by 30 · see citing works
Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin
Abelson, J. L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00182-2 · Cited by 30 · see citing works
Adrenocorticotropin and Cortisol Responses to Vasopressin during Pregnancy*
Goland, R., Wardlaw, S. L., MacCarter, G. D., Warren, W. B., & Stark, R. I. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-257 · Cited by 30 · see citing works
Vázquez-Borrego, M. C., Gahete, M. D., Martínez‐Fuentes, A. J., Fuentes-Fayos, A. C., Castano, J. P., Kineman, R. D., & Luque, R. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.007 · Cited by 29 · see citing works
Endocrine Response to High-Intensity Exercise: Dose-Dependent Effects of Dexamethasone
Deuster, P. A., Petrides, J. S., Singh, A. P., Chrousos, G. P., & Poth, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6444 · Cited by 28 · see citing works
Watanabe, T., & Orth, D. N. (1988) · Endocrinology · doi:10.1210/endo-122-5-2299 · Cited by 28 · see citing works
Self-citationHeinzmann, J.-M., Kloiber, S. M., Mattos, G. E., Bielohuby, M., Schmidt, M. V., Palme, R., Holsboer, F., Uhr, M., Ising, M., & Touma, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.008 · Cited by 27 · see citing works
Wied, C. C. G., Westenberg, H. G. M., Koppeschaar, H. P. F., Thijssen, J. H. H., & van Ree, J. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90003-q · Cited by 27 · see citing works
Vasopressin–neurophysin and DST in major depression: Relationship with suicidal behavior
Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.007 · Cited by 26 · see citing works
Gil‐Lozano, M., Romaní‐Pérez, M., Outeiriño‐Iglesias, V., Vigo, E., González-Matías, L. C., Brubaker, P. L., & Mallo, F. (2014) · Endocrinology · doi:10.1210/en.2013-1718 · Cited by 26 · see citing works
Meyerhoff, J. L., Oleshansky, M. A., Kalogeras, K. T., Mougey, E. H., Chrousos, G. P., & Granger, L. G. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_6 · Cited by 25 · see citing works
Michelson, D., & Gold, P. W. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09610.x · Cited by 25 · see citing works
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation
Hockings, G. I., Grice, J. E., Crosbie, G. V., Walters, M. M., Jackson, A. J., & Jackson, R. V. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.404 · Cited by 24 · see citing works
Self-citationRaff, H., Merrill, D., Skelton, M. M., Brownfield, M. S., & Cowley, A. W. (1988) · Endocrinology · doi:10.1210/endo-122-4-1410 · Cited by 24 · see citing works
Yadawa, A. K., & Chaturvedi, C. M. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.03.005 · Cited by 22 · see citing works
Hockings, G. I., Grice, J. E., Ward, W. K., Walters, M. M., Jensen, G. R., & Jackson, R. V. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90096-v · Cited by 22 · see citing works
Self-citationNaloxone‐induced ACTH release: mechanism of action in humans
Jackson, R. V., Grice, J. E., Hockings, G. I., & Torpy, D. J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02612.x · Cited by 21 · see citing works
Self-citationGrice, J. E., Jackson, J., Penfold, P. J., & Jackson, R. V. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00241.x · Cited by 21 · see citing works
Self-citationDeCherney, G. S., DEBOLD, C. R., Jackson, R. V., SHELDON, W. R., Kamilaris, T. C., Island, D. P., & Orth, D. N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1211 · Cited by 21 · see citing works
Self-citationGene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 20 · see citing works
- Authors
- DeBold, C. R., Sheldon, W. R., DeCherney, G. S., Jackson, R. V., Alexander, A. N., Vale, W., Rivier, J., & Orth, D. N.
- Affiliations
- Vanderbilt University (US)
- Salk Institute for Biological Studies (US)
- ORCID
- Vale, W
- Venue
- Journal of Clinical Investigation
- Published
- 1984-02-01
- Volume
- 73
- Issue
- 2
- Pages
- 533-538
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC425045
- OpenAlex
- W2007636157
- Cited by
- 189
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 3
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2t32am007061-12)
- Medical Research Council (19429)
- National Health and Medical Research Council
- National Cancer Institute
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- vasopressin, ACTH, ACTH release, corticotropin-releasing factor, ovine CRF, synergistic hormone interaction, cortisol, insulin-induced hypoglycemia, hypothalamic-pituitary-adrenal axis, stress response, plasma ACTH, plasma cortisol, human volunteers, dose-response relationship
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Corticotropin-Releasing Hormone, Drug Synergism, Humans, Hydrocortisone, Insulin, Kinetics, Male, Peptides, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review